These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents. Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD; BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®). Gandhi A; Balmer P; York LJ Postgrad Med; 2016 Aug; 128(6):548-56. PubMed ID: 27467048 [TBL] [Abstract][Full Text] [Related]
4. Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020). Honskus M; Krizova P; Okonji Z; Musilek M; Kozakova J PLoS One; 2023; 18(3):e0282971. PubMed ID: 36913385 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease. Watson PS; Turner DP Vaccine; 2016 Feb; 34(7):875-80. PubMed ID: 26686570 [TBL] [Abstract][Full Text] [Related]
6. From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Perez JL; Absalon J; Beeslaar J; Balmer P; Jansen KU; Jones TR; Harris S; York LJ; Jiang Q; Radley D; Anderson AS; Crowther G; Eiden JJ Expert Rev Vaccines; 2018 Jun; 17(6):461-477. PubMed ID: 29883226 [TBL] [Abstract][Full Text] [Related]
7. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine. Ruiz Garcia Y; Abitbol V; Pellegrini M; Bekkat-Berkani R; Soumahoro L Infect Dis Ther; 2022 Apr; 11(2):639-655. PubMed ID: 34591258 [TBL] [Abstract][Full Text] [Related]
8. The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci. Harris SL; Tan C; Andrew L; Hao L; Liberator PA; Absalon J; Anderson AS; Jones TR Vaccine; 2018 Oct; 36(45):6867-6874. PubMed ID: 30269916 [TBL] [Abstract][Full Text] [Related]
9. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp. Burman C; Alderfer J; Snow VT J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483 [TBL] [Abstract][Full Text] [Related]
10. Meningococcal serogroup B vaccines: Estimating breadth of coverage. Donald RG; Hawkins JC; Hao L; Liberator P; Jones TR; Harris SL; Perez JL; Eiden JJ; Jansen KU; Anderson AS Hum Vaccin Immunother; 2017 Feb; 13(2):255-265. PubMed ID: 27960595 [TBL] [Abstract][Full Text] [Related]
11. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile. Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520 [TBL] [Abstract][Full Text] [Related]
14. Broad vaccine protection against Neisseria meningitidis using factor H binding protein. Findlow J; Bayliss CD; Beernink PT; Borrow R; Liberator P; Balmer P Vaccine; 2020 Nov; 38(49):7716-7727. PubMed ID: 32878710 [TBL] [Abstract][Full Text] [Related]
15. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine. Pajon R; Lujan E; Granoff DM Vaccine; 2016 Jan; 34(5):643-649. PubMed ID: 26709637 [TBL] [Abstract][Full Text] [Related]
16. Vaccines against Meningococcal Diseases. Pizza M; Bekkat-Berkani R; Rappuoli R Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33022961 [No Abstract] [Full Text] [Related]
18. Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial. Peterson J; Drazan D; Czajka H; Maguire J; Pregaldien JL; Seppa I; Maansson R; O'Neill R; Balmer P; Jodar L; Jansen KU; Anderson AS; Perez JL; Beeslaar J Lancet Infect Dis; 2023 Dec; 23(12):1370-1382. PubMed ID: 37579773 [TBL] [Abstract][Full Text] [Related]
19. Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Dretler AW; Rouphael NG; Stephens DS Hum Vaccin Immunother; 2018 May; 14(5):1146-1160. PubMed ID: 29543582 [TBL] [Abstract][Full Text] [Related]
20. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. Mbaeyi SA; Bozio CH; Duffy J; Rubin LG; Hariri S; Stephens DS; MacNeil JR MMWR Recomm Rep; 2020 Sep; 69(9):1-41. PubMed ID: 33417592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]